APA

Huang L. Y. L., Chang C., Lee Y., Chang J., Huang J., Chuang S., Kao K., Lau G. M. G., Tsai P., Liu C., Lin H. & Lau J. Y. N. (20150219). Activity of a novel Hec1-targeted anticancer compound against breast cancer cell lines in vitro and in vivo. : Molecular cancer therapeutics.

Chicago

Huang Lynn Y L, Chang Chia-Chi, Lee Ying-Shuan, Chang Jia-Ming, Huang Jiann-Jyh, Chuang Shih-Hsien, Kao Kuo-Jang, Lau Gillian M G, Tsai Pei-Yi, Liu Chia-Wei, Lin Her-Sheng and Lau Johnson Y N. 20150219. Activity of a novel Hec1-targeted anticancer compound against breast cancer cell lines in vitro and in vivo. : Molecular cancer therapeutics.

Harvard

Huang L. Y. L., Chang C., Lee Y., Chang J., Huang J., Chuang S., Kao K., Lau G. M. G., Tsai P., Liu C., Lin H. and Lau J. Y. N. (20150219). Activity of a novel Hec1-targeted anticancer compound against breast cancer cell lines in vitro and in vivo. : Molecular cancer therapeutics.

MLA

Huang Lynn Y L, Chang Chia-Chi, Lee Ying-Shuan, Chang Jia-Ming, Huang Jiann-Jyh, Chuang Shih-Hsien, Kao Kuo-Jang, Lau Gillian M G, Tsai Pei-Yi, Liu Chia-Wei, Lin Her-Sheng and Lau Johnson Y N. Activity of a novel Hec1-targeted anticancer compound against breast cancer cell lines in vitro and in vivo. : Molecular cancer therapeutics. 20150219.